nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP3A4—Thiotepa—sarcoma	0.199	0.405	CbGbCtD
Hydrocodone—CYP3A4—Mitoxantrone—sarcoma	0.0855	0.174	CbGbCtD
Hydrocodone—CYP3A4—Vincristine—sarcoma	0.0588	0.12	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—sarcoma	0.0578	0.118	CbGbCtD
Hydrocodone—CYP3A4—Etoposide—sarcoma	0.0539	0.11	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—sarcoma	0.0368	0.0748	CbGbCtD
Hydrocodone—Naloxone—CREB1—sarcoma	0.0301	1	CrCbGaD
Hydrocodone—Dehydration—Vincristine—sarcoma	0.00416	0.0087	CcSEcCtD
Hydrocodone—Dehydration—Mitoxantrone—sarcoma	0.00405	0.00847	CcSEcCtD
Hydrocodone—Hypokalaemia—Mitoxantrone—sarcoma	0.00397	0.00829	CcSEcCtD
Hydrocodone—Agranulocytosis—Thiotepa—sarcoma	0.00363	0.00758	CcSEcCtD
Hydrocodone—Agranulocytosis—Dactinomycin—sarcoma	0.0036	0.00753	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.0035	0.00732	CcSEcCtD
Hydrocodone—Connective tissue disorder—Thiotepa—sarcoma	0.00343	0.00717	CcSEcCtD
Hydrocodone—Drowsiness—Mitoxantrone—sarcoma	0.00336	0.00702	CcSEcCtD
Hydrocodone—Urinary tract infection—Mitoxantrone—sarcoma	0.00326	0.00682	CcSEcCtD
Hydrocodone—Angiopathy—Thiotepa—sarcoma	0.00317	0.00662	CcSEcCtD
Hydrocodone—Mediastinal disorder—Thiotepa—sarcoma	0.00315	0.00658	CcSEcCtD
Hydrocodone—Agranulocytosis—Mitoxantrone—sarcoma	0.00313	0.00655	CcSEcCtD
Hydrocodone—Mental disorder—Thiotepa—sarcoma	0.00306	0.00639	CcSEcCtD
Hydrocodone—Connective tissue disorder—Vincristine—sarcoma	0.00304	0.00636	CcSEcCtD
Hydrocodone—Malnutrition—Thiotepa—sarcoma	0.00304	0.00635	CcSEcCtD
Hydrocodone—Back pain—Thiotepa—sarcoma	0.00294	0.00614	CcSEcCtD
Hydrocodone—Neck pain—Epirubicin—sarcoma	0.00283	0.00592	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Epirubicin—sarcoma	0.00283	0.00592	CcSEcCtD
Hydrocodone—Angiopathy—Vincristine—sarcoma	0.00281	0.00587	CcSEcCtD
Hydrocodone—Mediastinal disorder—Vincristine—sarcoma	0.00279	0.00583	CcSEcCtD
Hydrocodone—Mental disorder—Vincristine—sarcoma	0.00271	0.00567	CcSEcCtD
Hydrocodone—Cough—Thiotepa—sarcoma	0.00265	0.00554	CcSEcCtD
Hydrocodone—Convulsion—Thiotepa—sarcoma	0.00263	0.0055	CcSEcCtD
Hydrocodone—Neck pain—Doxorubicin—sarcoma	0.00262	0.00548	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Doxorubicin—sarcoma	0.00262	0.00548	CcSEcCtD
Hydrocodone—Agranulocytosis—Etoposide—sarcoma	0.00261	0.00545	CcSEcCtD
Hydrocodone—Back pain—Vincristine—sarcoma	0.00261	0.00545	CcSEcCtD
Hydrocodone—Myalgia—Thiotepa—sarcoma	0.00259	0.00541	CcSEcCtD
Hydrocodone—Arthralgia—Thiotepa—sarcoma	0.00259	0.00541	CcSEcCtD
Hydrocodone—Anxiety—Thiotepa—sarcoma	0.00258	0.00539	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00257	0.00537	CcSEcCtD
Hydrocodone—Myalgia—Dactinomycin—sarcoma	0.00257	0.00537	CcSEcCtD
Hydrocodone—Back pain—Mitoxantrone—sarcoma	0.00254	0.00531	CcSEcCtD
Hydrocodone—Nervous system disorder—Thiotepa—sarcoma	0.00243	0.00508	CcSEcCtD
Hydrocodone—Thrombocytopenia—Thiotepa—sarcoma	0.00243	0.00508	CcSEcCtD
Hydrocodone—Thrombocytopenia—Dactinomycin—sarcoma	0.00241	0.00504	CcSEcCtD
Hydrocodone—Skin disorder—Thiotepa—sarcoma	0.00241	0.00503	CcSEcCtD
Hydrocodone—Convulsion—Vincristine—sarcoma	0.00234	0.00488	CcSEcCtD
Hydrocodone—Myalgia—Vincristine—sarcoma	0.00229	0.00479	CcSEcCtD
Hydrocodone—Cough—Mitoxantrone—sarcoma	0.00229	0.00479	CcSEcCtD
Hydrocodone—Angiopathy—Etoposide—sarcoma	0.00228	0.00475	CcSEcCtD
Hydrocodone—Convulsion—Mitoxantrone—sarcoma	0.00227	0.00475	CcSEcCtD
Hydrocodone—Mediastinal disorder—Etoposide—sarcoma	0.00226	0.00472	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00226	0.00472	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00224	0.00469	CcSEcCtD
Hydrocodone—Arthralgia—Mitoxantrone—sarcoma	0.00223	0.00467	CcSEcCtD
Hydrocodone—Myalgia—Mitoxantrone—sarcoma	0.00223	0.00467	CcSEcCtD
Hydrocodone—Paraesthesia—Thiotepa—sarcoma	0.00223	0.00465	CcSEcCtD
Hydrocodone—Anxiety—Mitoxantrone—sarcoma	0.00223	0.00465	CcSEcCtD
Hydrocodone—Somnolence—Thiotepa—sarcoma	0.00221	0.00461	CcSEcCtD
Hydrocodone—Hot flush—Epirubicin—sarcoma	0.00217	0.00454	CcSEcCtD
Hydrocodone—Nervous system disorder—Vincristine—sarcoma	0.00216	0.00451	CcSEcCtD
Hydrocodone—Menopausal symptoms—Epirubicin—sarcoma	0.00215	0.0045	CcSEcCtD
Hydrocodone—Thrombocytopenia—Vincristine—sarcoma	0.00215	0.0045	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Thiotepa—sarcoma	0.00214	0.00448	CcSEcCtD
Hydrocodone—Fatigue—Thiotepa—sarcoma	0.00214	0.00447	CcSEcCtD
Hydrocodone—Hyperhidrosis—Vincristine—sarcoma	0.00213	0.00444	CcSEcCtD
Hydrocodone—Fatigue—Dactinomycin—sarcoma	0.00212	0.00444	CcSEcCtD
Hydrocodone—Constipation—Thiotepa—sarcoma	0.00212	0.00443	CcSEcCtD
Hydrocodone—Back pain—Etoposide—sarcoma	0.00211	0.00441	CcSEcCtD
Hydrocodone—Muscle spasms—Etoposide—sarcoma	0.0021	0.00439	CcSEcCtD
Hydrocodone—Thrombocytopenia—Mitoxantrone—sarcoma	0.0021	0.00438	CcSEcCtD
Hydrocodone—Skin disorder—Mitoxantrone—sarcoma	0.00208	0.00435	CcSEcCtD
Hydrocodone—Lethargy—Epirubicin—sarcoma	0.00207	0.00433	CcSEcCtD
Hydrocodone—Hyperhidrosis—Mitoxantrone—sarcoma	0.00207	0.00433	CcSEcCtD
Hydrocodone—Hypotension—Vincristine—sarcoma	0.00206	0.00429	CcSEcCtD
Hydrocodone—Pain in extremity—Epirubicin—sarcoma	0.00203	0.00425	CcSEcCtD
Hydrocodone—Osteoarthritis—Epirubicin—sarcoma	0.00203	0.00425	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Thiotepa—sarcoma	0.00203	0.00424	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Dactinomycin—sarcoma	0.00201	0.00421	CcSEcCtD
Hydrocodone—Hot flush—Doxorubicin—sarcoma	0.00201	0.0042	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Vincristine—sarcoma	0.002	0.00419	CcSEcCtD
Hydrocodone—Hypotension—Mitoxantrone—sarcoma	0.002	0.00418	CcSEcCtD
Hydrocodone—Migraine—Epirubicin—sarcoma	0.002	0.00418	CcSEcCtD
Hydrocodone—Affect lability—Epirubicin—sarcoma	0.002	0.00418	CcSEcCtD
Hydrocodone—Menopausal symptoms—Doxorubicin—sarcoma	0.00199	0.00416	CcSEcCtD
Hydrocodone—Insomnia—Vincristine—sarcoma	0.00199	0.00416	CcSEcCtD
Hydrocodone—Paraesthesia—Vincristine—sarcoma	0.00198	0.00413	CcSEcCtD
Hydrocodone—Abdominal pain—Thiotepa—sarcoma	0.00196	0.0041	CcSEcCtD
Hydrocodone—Body temperature increased—Thiotepa—sarcoma	0.00196	0.0041	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00195	0.00408	CcSEcCtD
Hydrocodone—Abdominal pain—Dactinomycin—sarcoma	0.00195	0.00407	CcSEcCtD
Hydrocodone—Body temperature increased—Dactinomycin—sarcoma	0.00195	0.00407	CcSEcCtD
Hydrocodone—Mood swings—Epirubicin—sarcoma	0.00193	0.00402	CcSEcCtD
Hydrocodone—Paraesthesia—Mitoxantrone—sarcoma	0.00192	0.00402	CcSEcCtD
Hydrocodone—Lethargy—Doxorubicin—sarcoma	0.00192	0.00401	CcSEcCtD
Hydrocodone—Dyspnoea—Mitoxantrone—sarcoma	0.00191	0.00399	CcSEcCtD
Hydrocodone—Cough—Etoposide—sarcoma	0.00191	0.00398	CcSEcCtD
Hydrocodone—Somnolence—Mitoxantrone—sarcoma	0.0019	0.00398	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Vincristine—sarcoma	0.0019	0.00397	CcSEcCtD
Hydrocodone—Fatigue—Vincristine—sarcoma	0.0019	0.00396	CcSEcCtD
Hydrocodone—Convulsion—Etoposide—sarcoma	0.00189	0.00395	CcSEcCtD
Hydrocodone—Dehydration—Epirubicin—sarcoma	0.00189	0.00395	CcSEcCtD
Hydrocodone—Constipation—Vincristine—sarcoma	0.00188	0.00393	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—sarcoma	0.00188	0.00393	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—sarcoma	0.00188	0.00393	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—sarcoma	0.00185	0.00387	CcSEcCtD
Hydrocodone—Migraine—Doxorubicin—sarcoma	0.00185	0.00387	CcSEcCtD
Hydrocodone—Hypokalaemia—Epirubicin—sarcoma	0.00185	0.00386	CcSEcCtD
Hydrocodone—Fatigue—Mitoxantrone—sarcoma	0.00185	0.00386	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00185	0.00386	CcSEcCtD
Hydrocodone—Constipation—Mitoxantrone—sarcoma	0.00183	0.00383	CcSEcCtD
Hydrocodone—Hypersensitivity—Thiotepa—sarcoma	0.00183	0.00382	CcSEcCtD
Hydrocodone—Hypersensitivity—Dactinomycin—sarcoma	0.00181	0.00379	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Vincristine—sarcoma	0.0018	0.00376	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—sarcoma	0.00178	0.00372	CcSEcCtD
Hydrocodone—Asthenia—Thiotepa—sarcoma	0.00178	0.00372	CcSEcCtD
Hydrocodone—Asthenia—Dactinomycin—sarcoma	0.00177	0.00369	CcSEcCtD
Hydrocodone—Pruritus—Thiotepa—sarcoma	0.00176	0.00367	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00175	0.00366	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—sarcoma	0.00175	0.00365	CcSEcCtD
Hydrocodone—Thrombocytopenia—Etoposide—sarcoma	0.00174	0.00365	CcSEcCtD
Hydrocodone—Body temperature increased—Vincristine—sarcoma	0.00174	0.00363	CcSEcCtD
Hydrocodone—Abdominal pain—Vincristine—sarcoma	0.00174	0.00363	CcSEcCtD
Hydrocodone—Skin disorder—Etoposide—sarcoma	0.00173	0.00362	CcSEcCtD
Hydrocodone—Hyperhidrosis—Etoposide—sarcoma	0.00172	0.0036	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—sarcoma	0.00171	0.00358	CcSEcCtD
Hydrocodone—Body temperature increased—Mitoxantrone—sarcoma	0.00169	0.00354	CcSEcCtD
Hydrocodone—Abdominal pain—Mitoxantrone—sarcoma	0.00169	0.00354	CcSEcCtD
Hydrocodone—Hypotension—Etoposide—sarcoma	0.00167	0.00348	CcSEcCtD
Hydrocodone—Dizziness—Thiotepa—sarcoma	0.00164	0.00343	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Epirubicin—sarcoma	0.00163	0.00341	CcSEcCtD
Hydrocodone—Hypersensitivity—Vincristine—sarcoma	0.00162	0.00339	CcSEcCtD
Hydrocodone—Paraesthesia—Etoposide—sarcoma	0.0016	0.00334	CcSEcCtD
Hydrocodone—Dyspnoea—Etoposide—sarcoma	0.00159	0.00332	CcSEcCtD
Hydrocodone—Somnolence—Etoposide—sarcoma	0.00158	0.00331	CcSEcCtD
Hydrocodone—Hypersensitivity—Mitoxantrone—sarcoma	0.00158	0.0033	CcSEcCtD
Hydrocodone—Asthenia—Vincristine—sarcoma	0.00158	0.0033	CcSEcCtD
Hydrocodone—Vomiting—Thiotepa—sarcoma	0.00158	0.0033	CcSEcCtD
Hydrocodone—Drowsiness—Epirubicin—sarcoma	0.00157	0.00327	CcSEcCtD
Hydrocodone—Vomiting—Dactinomycin—sarcoma	0.00157	0.00327	CcSEcCtD
Hydrocodone—Rash—Thiotepa—sarcoma	0.00156	0.00327	CcSEcCtD
Hydrocodone—Dermatitis—Thiotepa—sarcoma	0.00156	0.00327	CcSEcCtD
Hydrocodone—Headache—Thiotepa—sarcoma	0.00155	0.00325	CcSEcCtD
Hydrocodone—Rash—Dactinomycin—sarcoma	0.00155	0.00324	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Etoposide—sarcoma	0.00154	0.00321	CcSEcCtD
Hydrocodone—Asthenia—Mitoxantrone—sarcoma	0.00154	0.00321	CcSEcCtD
Hydrocodone—Fatigue—Etoposide—sarcoma	0.00154	0.00321	CcSEcCtD
Hydrocodone—Constipation—Etoposide—sarcoma	0.00152	0.00318	CcSEcCtD
Hydrocodone—Urinary tract infection—Epirubicin—sarcoma	0.00152	0.00318	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00151	0.00316	CcSEcCtD
Hydrocodone—Nausea—Thiotepa—sarcoma	0.00147	0.00308	CcSEcCtD
Hydrocodone—Nausea—Dactinomycin—sarcoma	0.00146	0.00306	CcSEcCtD
Hydrocodone—Agranulocytosis—Epirubicin—sarcoma	0.00146	0.00305	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Etoposide—sarcoma	0.00146	0.00304	CcSEcCtD
Hydrocodone—Dizziness—Vincristine—sarcoma	0.00145	0.00304	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—sarcoma	0.00145	0.00303	CcSEcCtD
Hydrocodone—Abdominal pain—Etoposide—sarcoma	0.00141	0.00294	CcSEcCtD
Hydrocodone—Body temperature increased—Etoposide—sarcoma	0.00141	0.00294	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—sarcoma	0.00141	0.00294	CcSEcCtD
Hydrocodone—Vomiting—Vincristine—sarcoma	0.0014	0.00292	CcSEcCtD
Hydrocodone—Rash—Vincristine—sarcoma	0.00139	0.0029	CcSEcCtD
Hydrocodone—Dermatitis—Vincristine—sarcoma	0.00139	0.0029	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—sarcoma	0.00139	0.00289	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—sarcoma	0.00138	0.00289	CcSEcCtD
Hydrocodone—Headache—Vincristine—sarcoma	0.00138	0.00288	CcSEcCtD
Hydrocodone—Vomiting—Mitoxantrone—sarcoma	0.00136	0.00285	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—sarcoma	0.00135	0.00283	CcSEcCtD
Hydrocodone—Rash—Mitoxantrone—sarcoma	0.00135	0.00282	CcSEcCtD
Hydrocodone—Dermatitis—Mitoxantrone—sarcoma	0.00135	0.00282	CcSEcCtD
Hydrocodone—Headache—Mitoxantrone—sarcoma	0.00134	0.0028	CcSEcCtD
Hydrocodone—Hypersensitivity—Etoposide—sarcoma	0.00131	0.00274	CcSEcCtD
Hydrocodone—Nausea—Vincristine—sarcoma	0.00131	0.00273	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—sarcoma	0.00128	0.00268	CcSEcCtD
Hydrocodone—Asthenia—Etoposide—sarcoma	0.00128	0.00267	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—sarcoma	0.00128	0.00267	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—sarcoma	0.00128	0.00267	CcSEcCtD
Hydrocodone—Nausea—Mitoxantrone—sarcoma	0.00127	0.00266	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—sarcoma	0.00127	0.00265	CcSEcCtD
Hydrocodone—Pruritus—Etoposide—sarcoma	0.00126	0.00263	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—sarcoma	0.00123	0.00257	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—sarcoma	0.00122	0.00256	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—sarcoma	0.00118	0.00247	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—sarcoma	0.00118	0.00247	CcSEcCtD
Hydrocodone—Dizziness—Etoposide—sarcoma	0.00118	0.00246	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—sarcoma	0.00118	0.00246	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—sarcoma	0.00117	0.00245	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—sarcoma	0.00114	0.00238	CcSEcCtD
Hydrocodone—Vomiting—Etoposide—sarcoma	0.00113	0.00237	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—sarcoma	0.00113	0.00237	CcSEcCtD
Hydrocodone—Rash—Etoposide—sarcoma	0.00112	0.00235	CcSEcCtD
Hydrocodone—Dermatitis—Etoposide—sarcoma	0.00112	0.00235	CcSEcCtD
Hydrocodone—Headache—Etoposide—sarcoma	0.00112	0.00233	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—sarcoma	0.0011	0.00229	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—sarcoma	0.00109	0.00227	CcSEcCtD
Hydrocodone—Cough—Epirubicin—sarcoma	0.00107	0.00223	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—sarcoma	0.00106	0.00222	CcSEcCtD
Hydrocodone—Nausea—Etoposide—sarcoma	0.00106	0.00221	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—sarcoma	0.00104	0.00218	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—sarcoma	0.00104	0.00218	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—sarcoma	0.00104	0.00217	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00103	0.00216	CcSEcCtD
Hydrocodone—Dry mouth—Epirubicin—sarcoma	0.00102	0.00213	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—sarcoma	0.000988	0.00206	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—sarcoma	0.000981	0.00205	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—sarcoma	0.00098	0.00205	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—sarcoma	0.000978	0.00204	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—sarcoma	0.00097	0.00203	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—sarcoma	0.000966	0.00202	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—sarcoma	0.000964	0.00201	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—sarcoma	0.000964	0.00201	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—sarcoma	0.000961	0.00201	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000957	0.002	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—sarcoma	0.000943	0.00197	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—sarcoma	0.000933	0.00195	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00091	0.0019	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—sarcoma	0.000906	0.00189	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—sarcoma	0.000905	0.00189	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—sarcoma	0.000903	0.00189	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—sarcoma	0.000898	0.00188	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—sarcoma	0.000897	0.00187	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—sarcoma	0.000893	0.00187	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—sarcoma	0.000891	0.00186	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—sarcoma	0.000888	0.00186	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—sarcoma	0.000864	0.0018	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000862	0.0018	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—sarcoma	0.000861	0.0018	CcSEcCtD
Hydrocodone—Constipation—Epirubicin—sarcoma	0.000854	0.00178	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000842	0.00176	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—sarcoma	0.000836	0.00175	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—sarcoma	0.00083	0.00173	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—sarcoma	0.000824	0.00172	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—sarcoma	0.000822	0.00172	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—sarcoma	0.000817	0.00171	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000798	0.00167	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—sarcoma	0.000797	0.00166	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—sarcoma	0.00079	0.00165	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—sarcoma	0.00079	0.00165	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—sarcoma	0.00079	0.00165	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000756	0.00158	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—sarcoma	0.000736	0.00154	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—sarcoma	0.000731	0.00153	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—sarcoma	0.000731	0.00153	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—sarcoma	0.000717	0.0015	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—sarcoma	0.000707	0.00148	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—sarcoma	0.000681	0.00142	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—sarcoma	0.000663	0.00139	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—sarcoma	0.000661	0.00138	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—sarcoma	0.000654	0.00137	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—sarcoma	0.000635	0.00133	CcSEcCtD
Hydrocodone—Rash—Epirubicin—sarcoma	0.00063	0.00132	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—sarcoma	0.000629	0.00131	CcSEcCtD
Hydrocodone—Headache—Epirubicin—sarcoma	0.000626	0.00131	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—sarcoma	0.000611	0.00128	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—sarcoma	0.000593	0.00124	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—sarcoma	0.000588	0.00123	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—sarcoma	0.000583	0.00122	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—sarcoma	0.000582	0.00122	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—sarcoma	0.000579	0.00121	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—sarcoma	0.000549	0.00115	CcSEcCtD
